Pseudoviruses expressing the GPC of LASV from lineages II, III or IV were employed to assess the ability of antibodies from Lassa fever survivors to cross-neutralize different lineages of LASV (Fig. 6). The gene discussed is GYPC; the disease is Lassa fever.